We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 33

Global Deregulation in Cannabinoid Market Sparks Flurry of Innovation From Dynamic Startups
  • Clarivate Analytics
  • USA, Australia, Canada, Global
  • November 8 2018

Analysis of Derwent patent data conducted by Clarivate Analytics indicates startups in the US, Canada, and Australia are the market leaders in the


Money in the Pot: The impact of deregulation on cannabinoids innovation
  • Clarivate Analytics
  • USA, Global
  • November 8 2018

The subject of Cannabinoids has been in many headlines recently. Nearly a century after it was listed as a prohibited substance in the United States


Cannabis: what's new for the 6000 year old medicine?
  • Taylor Wessing
  • United Kingdom
  • November 8 2018

Recent changes to the rules in the UK have raised some interesting possibilities and questions


Demand for Marijuana About to Heat Up?
  • Bennett & Philp Lawyers Pty Ltd
  • Australia
  • October 24 2018

Marijuana (also known as cannabis and by several other names) has been used throughout most of recorded history for medicinal, spiritual and


The great hemp debate: marijuana or not?
  • Sanchez-DeVanny Eseverri SC
  • Mexico
  • September 19 2018

Although Mexico has some of the most stringent regulations regarding the growth, use and marketing of marijuana, this position has recently changed


The evolution of CBD in South Africa
  • Hogan Lovells
  • South Africa
  • May 1 2018

During the past several decades, the advances made in the life sciences and health care industries have been astounding, not to mention revolutionary


FDA Issues Warning to Four Companies Marketing Cannabidiol Containing Products as Anti-Cancer Treatment
  • FisherBroyles LLP
  • USA
  • November 6 2017

On November 1, 2017, the U.S. Food and Drug Administration issued warning letters to four companies that were illegally marketing and selling products


The Failure to Warn of Cannabinoid Hyperemesis Syndrome
  • Cozen O'Connor
  • USA
  • February 22 2017

As more states legalize marijuana for recreational use, the long-term effects of marijuana use the good and the bad will continue to have a


Legislating for the medical use of cannabis based medicinal products
  • Eversheds Sutherland (International) LLP
  • Ireland
  • February 22 2017

Currently cannabis and products extracted from the cannabis plant are controlled under the Misuse of Drugs Acts 1977 to 2016 (the “Misuse of Drugs


Unión Europea - Enero 2017
  • Gómez-Acebo & Pombo Abogados
  • European Union
  • January 19 2017

Decisión de Ejecución (UE) 20162113 de la Comisión, de 30 de noviembre de 2016, relativa a la liquidación de las cuentas de los organismos pagadores